ELEVANCE HEALTH INC (A58.DE) Forecast, Price Target & Analyst Ratings

FRA:A58 • US0367521038

Current stock price

255.8 EUR
+1.3 (+0.51%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ELEVANCE HEALTH INC (A58.DE).

Forecast Snapshot

Consensus Price Target

Price Target
€338.62
+ 32.38% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 20, 2026
Period
Q1 / 2026
EPS Estimate
$10.79
Revenue Estimate
49.148B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
75.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€338.62
Upside
+ 32.38%
From current price of €255.80 to mean target of €338.62, Based on 28 analyst forecasts
Low
€283.10
Median
€338.44
High
€435.67

Price Target Revisions

1 Month
0.00%
3 Months
0.83%

Price Target Summary

28 Wall Street analysts provided a forecast for the next 12 months for A58.DE. The average price target is 338.62 EUR. This implies a price increase of 32.38% is expected in the next year compared to the current price of 255.8.
The average price target has been revised upward by 0.83% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

A58 Current Analyst RatingA58 Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

A58 Historical Analyst RatingsA58 Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
75.00%
A58.DE was analyzed by 28 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about A58.DE.
In the previous month the buy percentage consensus was at a similar level.
A58.DE was analyzed by 28 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 20, 2026
Period
Q1 / 2026
EPS Estimate
$10.79
Revenue Estimate
49.148B
Revenue Q2Q
0.79%
EPS Q2Q
-9.84%
Number of Analysts
21

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-4.63%
EPS (1 Month)
0.00%
EPS (3 Months)
-0.28%

Next Earnings Summary

A58.DE is expected to report earnings on 4/20/2026. The consensus EPS estimate for the next earnings is 10.79 EUR and the consensus revenue estimate is 49.15B EUR.
The next earnings revenue estimate has been revised downward by 4.63% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
A58.DE revenue by date.A58.DE revenue by date.
171.34B
9.42%		176.81B
3.19%		199.125B
12.62%		194.869B
-2.14%		200.549B
2.91%		210.758B
5.09%		222.661B
5.65%		N/AN/AN/AN/A
EBITDA
YoY % growth
A58.DE ebitda by date.A58.DE ebitda by date.
11.242B
10.60%		10.549B
-6.16%		9.658B
-8.45%		9.376B
-2.92%		10.198B
8.77%		10.924B
7.12%		11.971B
9.58%		13.341B
11.44%		14.06B
5.39%		15.321B
8.97%		16.732B
9.21%
EBIT
YoY % growth
A58.DE ebit by date.A58.DE ebit by date.
9.497B
11.86%		9.156B
-3.59%		8.112B
-11.40%		8.771B
8.12%		9.469B
7.96%		10.851B
14.59%		12.57B
15.84%		N/AN/AN/AN/A
Operating Margin
A58.DE operating margin by date.A58.DE operating margin by date.
5.54%5.18%4.07%4.50%4.72%5.15%5.65%N/AN/AN/AN/A
EPS
YoY % growth
A58.DE eps by date.A58.DE eps by date.
33.11
13.98%		32.97
-0.42%		30.17
-8.49%		26.16
-13.28%		29.36
12.21%		34.46
17.38%		42.37
22.95%		45.48
7.34%		47.27
3.93%		52.80
11.71%		59.09
11.90%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		10.79
-9.84%		6.53
-26.11%		5.57
-7.66%		3.34
0.15%		12.26
13.64%		8.94
36.92%		6.28
12.76%		3.34
0.04%
Revenue
Q2Q % growth		49.148B
0.79%		49.09B
-0.67%		52.778B
5.37%		51.93B
5.31%		53.68B
9.22%		54.726B
11.48%		55.99B
6.09%		54.851B
5.62%
EBITDA
Q2Q % growth		3.643B
3.67%		2.399B
-29.15%		2.056B
-29.03%		1.306B
-38.60%		4.086B
12.16%		3.008B
25.39%		2.147B
4.43%		1.445B
10.64%
EBIT
Q2Q % growth		3.519B
12.03%		2.355B
-10.56%		1.863B
6.03%		977.52M
68.25%		3.665B
4.15%		2.757B
17.07%		1.94B
4.13%		1.105B
13.04%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

A58.DE Yearly Revenue VS EstimatesA58.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50B 100B 150B 200B
A58.DE Yearly EPS VS EstimatesA58.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40 50

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
4.53%
EPS Next 5 Year
8.55%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
1.72%
Revenue Next 5 Year
2.69%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
4.05%
EBIT Next 5 Year
6.59%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ELEVANCE HEALTH INC / A58.DE Forecast FAQ

What do analysts expect the price target to be for ELEVANCE HEALTH INC (A58.DE)?

28 analysts have analysed A58.DE and the average price target is 338.62 EUR. This implies a price increase of 32.38% is expected in the next year compared to the current price of 255.8.

When does ELEVANCE HEALTH INC (A58.DE) report earnings?

ELEVANCE HEALTH INC (A58.DE) will report earnings on 2026-04-20, before the market open.

What are the consensus estimates for A58 stock next earnings?

The consensus EPS estimate for the next earnings of ELEVANCE HEALTH INC (A58.DE) is 10.79 EUR and the consensus revenue estimate is 49.15B EUR.

How do analysts rate ELEVANCE HEALTH INC (A58.DE)?

The consensus rating for ELEVANCE HEALTH INC (A58.DE) is 75 / 100 . This indicates that analysts generally have a positive outlook on the stock.